ABUS Stock Analysis: Buy, Sell, or Hold?
ABUS - Arbutus Biopharma Corporation Common Stock
$4.45
-0.07 (-1.55%)
▼
5d:
+3.01%
30d:
+0.23%
90d:
+0.68%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When ABUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ABUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ABUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: ABUS is currently trading at $4.45, which is considered slightly high relative to its 30-day fair value range of $4.23 to $4.52.
Technical Outlook: Technically, ABUS is showing sideways momentum. Immediate support is located at $4.06, while resistance sits at $4.79.
Market Sentiment: ABUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.07 (+13.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABUS is showing sideways momentum. Immediate support is located at $4.06, while resistance sits at $4.79.
Market Sentiment: ABUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.07 (+13.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.23 -
$4.52
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.3%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($5.07)
Trading Range Analysis
30-Day Trading Range
$4.23 -
$4.52
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.06
Resistance Level
$4.79
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.89
Wall Street Target
$5.07
(+13.9%)
Revenue Growth (YoY)
10054.5%
Profit Margin
84.0%
Share & Embed Analysis
Last updated: June 24, 2026 12:29 AM ET
Data refreshes hourly during market hours. Next update: 1:29 AM
Data refreshes hourly during market hours. Next update: 1:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$8 | 60 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 59 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$39 | 61 BUY |
Advanced ABUS Option Strategies
Professional options setups generated by AI based on today's ABUS price and gamma walls.
